JP2024156964A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024156964A5 JP2024156964A5 JP2024133744A JP2024133744A JP2024156964A5 JP 2024156964 A5 JP2024156964 A5 JP 2024156964A5 JP 2024133744 A JP2024133744 A JP 2024133744A JP 2024133744 A JP2024133744 A JP 2024133744A JP 2024156964 A5 JP2024156964 A5 JP 2024156964A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- kda
- seq
- protein
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1807378.3A GB201807378D0 (en) | 2018-05-04 | 2018-05-04 | Vaccine composition |
| GBGB1807376.7A GB201807376D0 (en) | 2018-05-04 | 2018-05-04 | HMCV Vaccine Composition |
| GB1807378.3 | 2018-05-04 | ||
| GB1807376.7 | 2018-05-04 | ||
| PCT/GB2019/051245 WO2019211630A2 (en) | 2018-05-04 | 2019-05-03 | Vaccine composition |
| JP2021510553A JP7575096B2 (ja) | 2018-05-04 | 2019-05-03 | ワクチン組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510553A Division JP7575096B2 (ja) | 2018-05-04 | 2019-05-03 | ワクチン組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024156964A JP2024156964A (ja) | 2024-11-06 |
| JP2024156964A5 true JP2024156964A5 (cg-RX-API-DMAC10.html) | 2025-01-21 |
| JP7882546B2 JP7882546B2 (ja) | 2026-06-30 |
Family
ID=66484095
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510553A Active JP7575096B2 (ja) | 2018-05-04 | 2019-05-03 | ワクチン組成物 |
| JP2024133744A Active JP7882546B2 (ja) | 2018-05-04 | 2024-08-09 | ワクチン組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510553A Active JP7575096B2 (ja) | 2018-05-04 | 2019-05-03 | ワクチン組成物 |
Country Status (11)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12433944B2 (en) * | 2018-05-04 | 2025-10-07 | SpyBiotech Limited | Vaccine composition |
| GB201917265D0 (en) * | 2019-11-27 | 2020-01-08 | Univ Sheffield | Bonded neurotoxins |
| AU2020402106A1 (en) | 2019-12-11 | 2022-07-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mumps and Measles virus immunogens and their use |
| CN114634578B (zh) * | 2020-12-15 | 2024-04-02 | 榕森生物科技(北京)有限公司 | 针对新型冠状病毒感染的疫苗组合物 |
| WO2022129547A1 (en) * | 2020-12-18 | 2022-06-23 | University Of Copenhagen | Nucleic acid vaccines |
| US20240240203A1 (en) * | 2021-05-04 | 2024-07-18 | SpyBiotech Limited | Adenoviral vectors and vaccines thereof |
| US20250157651A1 (en) * | 2022-01-19 | 2025-05-15 | Trustees Of Dartmouth College | Systems and methods for deterring viral transmission using neural networks |
| US12492266B2 (en) | 2022-02-21 | 2025-12-09 | Youcare Pharmaceutical Group Co., Ltd. | Method for optimizing virus membrane fusion inhibitor, broad-spectrum anti-coronavirus lipopeptide and use thereof |
| CN115920026B (zh) * | 2022-04-02 | 2023-11-14 | 中山大学 | 耐热性多聚体蛋白支架、耐热性多聚体蛋白支架在疫苗中的应用 |
| CN115010812B (zh) * | 2022-04-12 | 2024-06-21 | 河南省龙星生物科技有限公司 | 一种非洲猪瘟抗原介导细胞免疫的多聚体及应用 |
| CN116041536A (zh) * | 2022-09-15 | 2023-05-02 | 山西大学 | 一种多接头自组装蛋白纳米颗粒的制备方法与应用 |
| CN117462666B (zh) * | 2022-09-30 | 2024-07-30 | 烟台派诺生物技术有限公司 | 一种预防或治疗水痘-带状疱疹病毒相关疾病的免疫组合物产品及其制备方法 |
| CN117264074A (zh) * | 2023-01-12 | 2023-12-22 | 东沃同泰(凤城)生物工程有限公司 | 靶向DCs递送的耐热性纳米颗粒蛋白、纳米载体、免疫原性复合物和纳米颗粒疫苗及应用 |
| CN117050149B (zh) * | 2023-05-19 | 2025-12-12 | 珠海丽凡达生物技术有限公司 | 包含人呼吸道合胞病毒抗原的免疫组合物及其制备方法和应用 |
| CN117264081B (zh) * | 2023-11-21 | 2025-03-21 | 华南理工大学 | 一种双肽受体激动剂及其制备方法与应用 |
| CN118373888B (zh) * | 2024-06-27 | 2024-08-30 | 普大生物科技(泰州)有限公司 | 一种水痘-带状疱疹病毒纳米颗粒蛋白及其制备方法和应用 |
| WO2026028158A1 (en) * | 2024-07-31 | 2026-02-05 | Biohaven Therapeutics Ltd. | Targeted degradation of anti-aav antibodies to enable aav-based gene therapy |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474914A (en) | 1992-07-29 | 1995-12-12 | Chiron Corporation | Method of producing secreted CMV glycoprotein H |
| US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| US8563002B2 (en) | 2007-12-24 | 2013-10-22 | Glaxosmithkline Biologicals, S.A. | Recombinant RSV antigens |
| WO2011009877A1 (de) | 2009-07-24 | 2011-01-27 | Basf Se | Flammgeschützte polyamidformmassen |
| GB201002362D0 (en) | 2010-02-11 | 2010-03-31 | Isis Innovation | Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds |
| EP2614072A4 (en) | 2010-09-09 | 2014-03-19 | Univ Virginia Commonwealth | VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS |
| JP6232544B2 (ja) | 2011-11-11 | 2017-11-22 | ヴァリエーション バイオテクノロジーズ インコーポレイテッド | サイトメガロウイルスの治療のための組成物及び方法 |
| AU2013286093B2 (en) | 2012-07-06 | 2018-01-04 | Novartis Ag | Complexes of cytomegalovirus proteins |
| EP4421177A3 (en) | 2013-03-13 | 2024-12-18 | The United States of America, as represented by the Secretary, Department of Health and Human Services | Prefusion rsv f proteins and their use |
| JP7060324B2 (ja) | 2013-12-20 | 2022-04-26 | ザ・ブロード・インスティテュート・インコーポレイテッド | ネオ抗原ワクチンによる併用療法 |
| EP3015475A1 (en) | 2014-10-31 | 2016-05-04 | Novartis AG | Mammalian cells expressing cytomegalovirus antigens |
| AU2016207099C1 (en) * | 2015-01-15 | 2021-02-04 | University Of Copenhagen | Virus-like particle with efficient epitope display |
| GB201509782D0 (en) | 2015-06-05 | 2015-07-22 | Isis Innovation | Methods and products for fusion protein synthesis |
| CN115960263A (zh) | 2016-03-29 | 2023-04-14 | 美国政府(由卫生和人类服务部的部长所代表) | 取代修饰的融合前rsv f蛋白及其用途 |
| CN106081304A (zh) | 2016-07-27 | 2016-11-09 | 佛山市高明金荣华乐金属制品有限公司 | 一种新型可折叠箱体及其拆装方法 |
| GB201705750D0 (en) | 2017-04-10 | 2017-05-24 | Univ Oxford Innovation Ltd | Peptide ligase and use therof |
| GB201706430D0 (en) | 2017-04-24 | 2017-06-07 | Univ Oxford Innovation Ltd | Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof |
| US12433944B2 (en) | 2018-05-04 | 2025-10-07 | SpyBiotech Limited | Vaccine composition |
-
2019
- 2019-05-03 US US17/052,707 patent/US12433944B2/en active Active
- 2019-05-03 CA CA3099381A patent/CA3099381A1/en active Pending
- 2019-05-03 BR BR112020022393-0A patent/BR112020022393A2/pt unknown
- 2019-05-03 CN CN201980044956.2A patent/CN112638411B/zh active Active
- 2019-05-03 WO PCT/GB2019/051245 patent/WO2019211630A2/en not_active Ceased
- 2019-05-03 SG SG11202010821TA patent/SG11202010821TA/en unknown
- 2019-05-03 EP EP19723480.0A patent/EP3787676A2/en active Pending
- 2019-05-03 IL IL278418A patent/IL278418B2/en unknown
- 2019-05-03 AU AU2019263706A patent/AU2019263706B2/en active Active
- 2019-05-03 JP JP2021510553A patent/JP7575096B2/ja active Active
- 2019-05-03 KR KR1020207034602A patent/KR20210013571A/ko active Pending
- 2019-05-03 CN CN202510197781.6A patent/CN120040601A/zh active Pending
-
2024
- 2024-08-09 JP JP2024133744A patent/JP7882546B2/ja active Active
-
2025
- 2025-09-09 US US19/323,644 patent/US20260007740A1/en active Pending
-
2026
- 2026-02-12 AU AU2026201020A patent/AU2026201020A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7575096B2 (ja) | ワクチン組成物 | |
| JP7189014B2 (ja) | Rsvに対するワクチン | |
| AU2007239354B2 (en) | N protein fusion proteins of a virus in the Paramyxoviridae-protein of interest family | |
| JP2023530434A (ja) | コロナウイルスワクチン組成物、方法、及びその使用 | |
| CN112469661A (zh) | 具有新结构组分的纳米粒疫苗 | |
| JP2013503159A5 (cg-RX-API-DMAC10.html) | ||
| CN101932594A (zh) | 可用作疫苗的自装配肽纳米颗粒 | |
| JP2013501038A5 (cg-RX-API-DMAC10.html) | ||
| CN114929877A (zh) | 突变型rsv f蛋白及其利用 | |
| JP2020536489A5 (cg-RX-API-DMAC10.html) | ||
| JP5545209B2 (ja) | 免疫原性を有する物質 | |
| JP7602457B2 (ja) | ペプチド核酸を基盤としたアジュバント | |
| JP2021533772A (ja) | フィロウイルス糖タンパク質の安定化された三量体 | |
| CN113430178A (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| Li et al. | Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection | |
| WO2002078732A1 (en) | A noval vaccine formulation consisting of dna vaccine inactivated virus | |
| HK40127919A (en) | Vaccine composition | |
| CN114409802B (zh) | 禽流感病毒三聚体亚单位疫苗及其应用 | |
| CN120548366A (zh) | 疫苗 | |
| HK40098178A (en) | Human metapneumovirus vaccine | |
| AU2001297689A1 (en) | A noval vaccine formulation consisting of DNA vaccine inactivated virus | |
| ZA200304631B (en) | A novel vaccine formulation consisting of DNA vaccine inactivated virus. |